血栓通联合依达拉奉治疗急性脑梗死患者的效果及其神经功能、实验室指标分析

打开文本图片集

【摘要】目的：分析血栓通联合依达拉奉治疗急性脑梗死患者的效果及其神经功能、实验室指标。方法：2019年9月—2021年8月，从本院收治的急性脑梗死患者中选取130例，按照选取顺序编号，抽签分两组，各65例，对照组实施依达拉奉治疗，试验组实施血栓通联合依达拉奉治疗，比较两组治疗效果。结果：试验组治疗总有效率为96.93%，高于对照组86.15%（P0.05）；治疗后两组NIHSS评分、IL-6、TNF-α水平均低于治疗前（P

【关键词】急性脑梗死；血栓通；依达拉奉；神经功能；实验室指标

Effect of Xueshuantong and edaravone in the treatment of patients with acute cerebral infarction and analysis of its neurological function and laboratory indexes

LI Jian， DONG Jing

Xixiang County People’s Hospital， Hanzhong， Shaanxi， 723500， China

【Abstract】Objective： To analyze the effect of Xueshuantong and edaravone in the treatment of patients with acute cerebral infarction and its neurological function and laboratory indicators. Methods： From September 2019 to August 2021， 130 patients with acute cerebral infarction admitted to our hospital were selected. Numbered according to the order of selection， and divided into two groups by lottery， each with 65 cases. The control group was treated with edaravone， and the experimental group was treated with Xueshuantong and edaravone. The treatment effects of the two groups were compared. Results： The total effective rate of the experimental group was 96.93%， which was higher than that of the control group， 86.15%（P0.05）. After treatment， the NIHSS scores， IL-6， and TNF-α levels in the two groups were lower than those before treatment（P

【Key words】acute cerebral infarction； Xueshuantong； edaravone； neurological function； laboratory indicators

急性脑梗死是常见脑血管疾病，具体发病与血栓形成、脑组织缺氧缺血有关，目前我国居民饮食结构、生活方式不断发生变化，且生活节奏加快，导致此疾病发病率呈上升趋势，而急性脑梗死患者伴有明显神经功能缺损问题，死亡率较高，严重威胁患者生命安全[1-2]。（剩余3473字）